Literature DB >> 19834114

Childhood NAFLD: a ticking time-bomb?

Valerio Nobili1, Chris Day.   

Abstract

Mesh：

Year:  2009        PMID： 19834114     DOI： 10.1136/gut.2009.184465

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model.

Authors:  R Scott Rector; Grace M Uptergrove; E Matthew Morris; Sarah J Borengasser; M Harold Laughlin; Frank W Booth; John P Thyfault; Jamal A Ibdah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

2.  Changes of liver fat content and transaminases in obese children after 12-mo nutritional intervention.

Authors:  Elvira Verduci; Carlo Pozzato; Giuseppe Banderali; Giovanni Radaelli; Chiara Arrizza; Antonio Rovere; Enrica Riva; Marcello Giovannini
Journal:  World J Hepatol       Date:  2013-09-27

3.  Biomarkers in nonalcoholic fatty liver disease: a new era in diagnosis and staging of disease in children.

Authors:  Ariel E Feldstein; Valerio Nobili
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-10       Impact factor: 2.839

4.  Sedentary Behavior and Cardiometabolic Health Associations in Obese 11-13-Year Olds.

Authors:  Gregory J Norman; Jordan A Carlson; Kevin Patrick; Julia K Kolodziejczyk; Job G Godino; Jeannie Huang; John Thyfault
Journal:  Child Obes       Date:  2017-06-02       Impact factor: 2.992

Review 5.  A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD.

Authors:  Mary P Moore; Rory P Cunningham; Ryan J Dashek; Justine M Mucinski; R Scott Rector
Journal:  Obesity (Silver Spring)       Date:  2020-09-06       Impact factor: 5.002

6.  Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study.

Authors:  Shih-Chang Hung; Kuan-Fu Liao; Shih-Wei Lai; Chia-Ing Li; Wen-Chi Chen
Journal:  BMC Gastroenterol       Date:  2011-10-17       Impact factor: 3.067

7.  Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease.

Authors:  Qi Xie; Shuqing Gao; Min Lei; Zengning Li
Journal:  Aging (Albany NY)       Date:  2022-02-10       Impact factor: 5.682

Review 8.  Surgical treatment of obesity.

Authors:  Vance L Albaugh; Naji N Abumrad
Journal:  F1000Res       Date:  2018-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.